BALLESTRI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.364
AS - Asia 2.434
EU - Europa 2.302
SA - Sud America 344
AF - Africa 50
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.511
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.303
SG - Singapore 819
CN - Cina 622
GB - Regno Unito 603
VN - Vietnam 305
FI - Finlandia 285
HK - Hong Kong 278
BR - Brasile 249
PL - Polonia 243
SE - Svezia 232
IT - Italia 216
DE - Germania 215
RU - Federazione Russa 111
FR - Francia 104
UA - Ucraina 99
TR - Turchia 82
IN - India 56
BG - Bulgaria 48
ID - Indonesia 38
BD - Bangladesh 36
JP - Giappone 36
AR - Argentina 34
KR - Corea 32
CA - Canada 30
LT - Lituania 28
NL - Olanda 24
MX - Messico 18
ZA - Sudafrica 16
IQ - Iraq 15
PK - Pakistan 15
VE - Venezuela 15
EC - Ecuador 13
MY - Malesia 13
ES - Italia 12
PH - Filippine 12
IE - Irlanda 11
CZ - Repubblica Ceca 10
GR - Grecia 10
UZ - Uzbekistan 10
SA - Arabia Saudita 9
BE - Belgio 8
CO - Colombia 8
BO - Bolivia 7
CL - Cile 7
AT - Austria 6
AU - Australia 6
EG - Egitto 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PE - Perù 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
OM - Oman 5
SI - Slovenia 5
DZ - Algeria 4
EU - Europa 4
MA - Marocco 4
TH - Thailandia 4
TW - Taiwan 4
AL - Albania 3
CH - Svizzera 3
IL - Israele 3
JO - Giordania 3
LB - Libano 3
RS - Serbia 3
SV - El Salvador 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
IR - Iran 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
NO - Norvegia 2
PT - Portogallo 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
GH - Ghana 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
Totale 11.497
Salva come PNG Salva come JPEG
Città #
Fairfield 759
Ashburn 582
Singapore 543
Santa Clara 486
Woodbridge 461
Houston 360
Southend 338
Seattle 336
Chandler 312
Wilmington 301
Hong Kong 274
Helsinki 255
Cambridge 246
Warsaw 241
San Jose 218
Dearborn 192
Ann Arbor 182
Nyköping 165
Jacksonville 137
Beijing 125
London 115
Chicago 109
Hefei 107
New York 107
Council Bluffs 99
Los Angeles 90
Ho Chi Minh City 87
Modena 80
Hanoi 75
The Dalles 56
Sofia 46
Eugene 43
Izmir 43
Princeton 43
Salt Lake City 43
San Diego 43
Lauterbourg 36
Moscow 35
Seoul 30
Shanghai 30
Frankfurt am Main 25
Jakarta 24
Tokyo 24
Munich 23
São Paulo 23
Dallas 22
Buffalo 21
Tampa 21
Manchester 19
Elk Grove Village 18
Redwood City 17
Chennai 15
Orem 15
Columbus 14
Da Nang 14
Des Moines 14
Phoenix 14
Haiphong 12
San Mateo 12
Amsterdam 11
Denver 11
Dublin 11
Guangzhou 11
Athens 10
Boardman 10
Dong Ket 10
Kansas City 10
Rome 10
Bremen 9
Kunming 9
Lancaster 9
North Salt Lake 9
Paris 9
Redondo Beach 9
San Francisco 9
Tashkent 9
Biên Hòa 8
Brno 8
Jersey City 8
Johannesburg 8
Nanjing 8
Padova 8
Palisades Park 8
Schiffdorf 8
Atlanta 7
Baghdad 7
Brussels 7
Buenos Aires 7
Falls Church 7
Milan 7
Naples 7
Norwalk 7
Poplar 7
Rio de Janeiro 7
Sterling 7
Stockholm 7
Toronto 7
Ankara 6
Auckland 6
Brooklyn 6
Totale 8.516
Salva come PNG Salva come JPEG
Nome #
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 474
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 428
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 408
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 390
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 375
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 371
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 364
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 354
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 349
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 345
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 341
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 325
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 314
Nonalcoholic fatty liver disease and aging: epidemiology to management 311
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 299
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 296
A critical appraisal of the use of ultrasound in hepatic steatosis 286
Clinical relevance of liver histopathology and different histological classifications of NASH in adults 273
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 271
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 270
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 269
Alcohol and Steatosis: The Japanese Paradox 268
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 264
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? 263
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 260
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 258
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 240
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 226
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 219
Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: Chance tetrad or association by necessity? 207
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 201
Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity? 198
Gli enzimi epatobiliari nella diagnostica clinica delle Epatopatie. 197
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 195
Nanoparticles: potential toxins for the organism and the kidney ? 194
Hypervascular Retroperitoneal Mass in a Patient with Fever and Leucocytosis - Contrast-Enhanced Ultrasonographic Findings in a Case of Inflammatory Malignant Fibrous Histiocytoma 193
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 187
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 186
Sex Differences in NAFLD: State of the Art and Identification of Research Gaps 176
NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk 165
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 163
Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral chronic liver disease 119
Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease 100
Totale 11.592
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.568
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021313 0 0 0 0 0 0 0 0 0 135 114 64
2021/2022782 34 95 77 31 17 37 48 29 102 75 172 65
2022/2023827 82 126 62 76 87 116 16 79 96 8 34 45
2023/2024457 15 25 42 24 97 61 21 39 10 4 56 63
2024/20251.754 48 21 36 121 361 252 143 135 178 71 167 221
2025/20263.680 221 108 241 411 652 562 602 177 430 276 0 0
Totale 11.592